Studies indicate that around 56.6% of women see improvement with oral spironolactone alone, while combining it with minoxidil boosts success rates to 65.8%
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Given the drugs impact on reducing appetites and calorie intake, increasing AOM prevalence can shape demand for food, beverages and restaurants, and we anticipate meaningful impact in areas such as packaged food and beverages, restaurants, grocery stores and weight loss programs. While its early days, AOM patients report a 23% reduction in daily meals and 50% reduction in snacks, according to Morgan Stanley
GIP receptor activation appears to influence adipose-tissue metabolism and insulin sensitivity in ways that may complement GLP-1s appetite and glycaemic effects
Oral semaglutide has significantly lower bioavailability than injectable semaglutide, so the dose numbers are not comparable
So far, research trials havent prompted regulatory agencies to approve these substances or convinced companies to invest in further development
